Clients, Interview

Everything You Need To Know About Prostate Cancer

deepak-kapoorEverything you need to know about prostate cancer

I recently had the opportunity to interview Dr. Deepak Kapoor, President of Advanced Urology Centers of New York.

Dr. Kapoor, what is Advanced Urology Centers of New York?

Advanced Urology Centers of New York (AUCNY), a division of Integrated Medical Professionals, PLLC, is the largest urology group practice in the United States. We have almost 100 Board Certified physicians in over 50 locations in Nassau, Suffolk, Queens, Manhattan, Rockland, Westchester County and the Bronx.

Question: How prevalent is prostate cancer?


American Cancer Society estimates 180,890 new cases of prostate cancer to be diagnosed in the United States in 2016. There will be 26,120 prostate cancer deaths expected this year. And, most importantly, it is the second leading cause of cancer death in men.

Question: What are the symptoms of prostate cancer?


  • The most common symptoms of prostate cancer is no symptoms
  • Symptoms associated with prostate cancer generally only appear once the disease has spread
  • Most symptoms in the urinary tract are related to other, more benign conditions such as BPH

Question: Who is at risk for prostate cancer?


  • Although prostate cancer is more prevalent in older men, all men, particularly 50 and older are at risk for prostate cancer
      • Particular risk factors for prostate cancer include:
        • African-American (or non-white Hispanic) heritage
        • Family history of prostate cancer (male relatives)
        • Toxin exposure such as Agent Orange

Question: What advice would you give men at the age of 45?


  • Baseline testing, diet, exercise, healthy lifestyle

Question: Do you think men are afraid to get screened for prostate cancer?


  • Men in general are less proactive about their health – it is important for men to be educated about their risk factors not only for prostate cancer, but for other disease states as well

Question: There seems to be a controversy concerning recommendations about PSA testing.  What is that about?


In 2012, the United States Preventative Services Task Force (USPSTF) gave a grade “D” recommendation regarding PSA-based prostate cancer screening. We believe that the USPSTF’s decision is based on incomplete and flawed data, an inappropriate superimposition of the risks of therapy onto the risks of screening and a misunderstanding for clinical changes that are occurring presently in the real world management of PSA screening.

Question: How did the prostate cancer screening controversy impact men’s health relating to prostate cancer?


  • There are fewer men being screened for prostate cancer.
  • There is an increasing incidence of metastatic prostate cancer in the US.  
  • The incidence of intermediate-risk prostate cancer was 23% more in 2013 compared with 2004.
  • The incidence of metastatic prostate cancer rose from 2007 to 2013 increasing to 72% compared with 2004.

Question: What is the survival rate for those diagnosed with prostate cancer?


  • 5-year relative survival rate for localized state: 100%
  • 10-year relative survival rate for all stages combined: 98%

Question: How do doctors know how far prostate cancer has progressed?


  • Gleason score
  • Stages

Question: What are the treatment options for men newly diagnosed with prostate cancer?


  • A number of options, depending on the stage and grade of the cancer, as well as the relative life expectancy of the patient.  The most common options are:
        • Active surveillance
        • Surgery (open, laparoscopic or robotic)
        • Radiation therapy (IMRT/IMGRT or Seed Implantation)

Question: What advice would you give to men about prostate cancer screening?


Talk to your doctor about whether screening is right for you. Early detection of prostate cancer saves lives.

Question: How can someone get in touch with you?


If someone wants to talk with our physicians or with me, they can contact AUCNY at

 855-7-UROLOGIST (855-787-6564)

Tagged , , ,